Scott Curry, M.D., is an assistant professor of medicine at MUSC who joined the division of infectious diseases in 2016. Dr. Curry grew up in Mount Pleasant and received a Bachelor of Science degree at Duke University, returning to MUSC for his medical degree. He completed his three-year internship and residency in internal medicine followed by a four-year clinical and research fellowship in infectious diseases at the University of Pittsburgh Medical Center, where he stayed on as junior faculty from 2008 to 2016. While in Pittsburgh, Dr. Curry did extensive laboratory and clinical research in Clostridium difficile and established his institution’s fecal microbiota transplant (FMT) program for treatment of recurrent C. difficile infections.
Dr. Curry is board-certified in internal medicine and infectious diseases and spends 75 percent of his time conducting clinical and laboratory research related to the transmission and prevention of C. difficile infections. The balance of his time is spent on the general infectious diseases inpatient service at MUSC as well as one half-day of clinic weekly. He also serves as assistant hospital epidemiologist at MUSC. His clinic is primarily devoted to the care of patients with recurrent Clostridium difficile infection, and he is starting an FMT program at MUSC that aims to be a regional and national model for safe delivery of this innovative therapy.
Dr. Curry’s clinical interests include general infectious diseases, infections in immunocompromised hosts, hospital epidemiology, clinical microbiology, C. difficile infections, and fecal microbiota transplantation. Dr. Curry’s research is supported by a K23 award from the National Institute of Allergy and Infectious Diseases (NIH/NIAID) and focuses on the role of asymptomatic carriers in the transmission of C. difficile within hospitals. He also conducts translational research in the optimization and safe conduct of fecal microbiota transplantation for treatment of C. difficile.